Protonation of phosphoramide mustard and other phosphoramides

Journal of Medicinal Chemistry
1993.0

Abstract

The chemistry of the bifunctional alkylating agent phosphoramide mustard and model phosphoramides was probed by multinuclear NMR spectroscopy as a function of pH. Between pH 1 and 11, both the 31P and 15N resonances for phosphoramide mustard displayed a single monobasic titration curve with a pKa of 4.9. The protonation below pH 4.9 correlates with the loss in reactivity of the mustard. The 17O NMR spectrum of 17O-enriched phosphoramide mustard shows little change with pH. The data on the mustard was compared to 15N and 31P NMR data on 15N-enriched phosphoramidic acid, phosphorodiamidic acid, and phosphoric triamide. Contrary to the conclusions of previous studies, our combined 31P, 15N, and 17O NMR results are more consistent with N-protonation of phosphoramide mustard rather than an O-protonation. Theoretical calculations on the phosphoramidic acid, phosphorodiamidic acid, and phosphoric triamide show O-protonation to be more stable in the gas phase. For the latter two compounds, the calculations suggest that N-protonation may be the most stable protonated form in the aqueous phase. These findings influence our understanding of the structure-activity relationships of phosphoramide mustards.

Knowledge Graph

Similar Paper

Protonation of phosphoramide mustard and other phosphoramides
Journal of Medicinal Chemistry 1993.0
Neuroactive Polyamine Wasp Toxins:  Nuclear Magnetic Resonance Spectroscopic Analysis of the Protolytic Properties of Philanthotoxin-343
Journal of Medicinal Chemistry 1996.0
Studying Lipophilicity Trends of Phosphorus Compounds by <sup>31</sup>P-NMR Spectroscopy: A Powerful Tool for the Design of P-Containing Drugs
Journal of Medicinal Chemistry 2022.0
NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways
Journal of Medicinal Chemistry 1984.0
Phosphoramidate ProTides of the Anticancer Agent FUDR Successfully Deliver the Preformed Bioactive Monophosphate in Cells and Confer Advantage over the Parent Nucleoside
Journal of Medicinal Chemistry 2011.0
Nitrogen-15 nuclear magnetic resonance spectroscopy. The nebramycin aminoglycosides
Journal of the American Chemical Society 1976.0
Conformation of the CYP2D6 model substrate sparteine under physiological conditions
Bioorganic &amp; Medicinal Chemistry Letters 1993.0
Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine
Journal of Medicinal Chemistry 1984.0
Phosphonate analogs of pyridoxal phosphate with shortened side chains
Journal of Medicinal Chemistry 1983.0
Synthesis and Biological Studies of Novel Nucleoside Phosphoramidate Prodrugs
Journal of Medicinal Chemistry 2001.0